JENNIFER KOTTLER: Open Payments
NPI 1740975366 · HUNLOCK CREEK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 66 payments from 11 companies in 2025. Trend: 2023 $158 · 2024 $496 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $241 |
| Otsuka America Pharmaceutical, Inc. | 10 | $183 |
| ABBVIE INC. | 14 | $181 |
| Janssen Pharmaceuticals, Inc | 7 | $123 |
| Alkermes, Inc. | 6 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $78 |
| Neurocrine BioSciences, Inc. | 5 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $63 |
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: VRAYLAR, AUSTEDO XR, INVEGA SUSTENNA, REXULTI, UZEDY, ARISTADA, CAPLYTA, INGREZZA.
Industry payments across PA — which companies pay providers there.
